Range
1.5 - 1.61
Vol / Avg.
2.6M/2.2M
Div / Yield
-
52 Wk
0.97 - 4.56
Mkt Cap
220.4M
Payout Ratio
-
Open
1.61
P/E
-
EPS
-0.05
Shares
146M
Outstanding
146M
Total Float
133.7M
load more
Sector: Health Care.Industry: Pharmaceuticals
Citius Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the development and commercialization of anti-infective products, adjunctive cancer care, and unique prescription products. Citius is currently advancing two proprietary product candidates, Mino-Lok product and a Hydrocortisone-Lidocaine formulation. Mino-Lok product is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections. The company's Hydrocortisone-Lidocaine provides anti-inflammatory and anesthetic relief to patients suffering from Grade I and II hemorrhoids. It is primarily operating within the critical care and cancer care market segments.

Earnings

see more
Q1 2022Est.ActualSurprise
EPS
(EXPECTED)2022-02-10
REV
Q4 2021Est.ActualSurprise
EPS
(EXPECTED)2021-12-20
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Citius Pharmaceuticals Questions & Anwsers

Q

How do I buy Citius Pharmaceuticals (CTXR) stock?

A

You can purchase shares of Citius Pharmaceuticals (NASDAQ: CTXR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Citius Pharmaceuticals's (CTXR) competitors?

Q

What is the target price for Citius Pharmaceuticals (CTXR) stock?

A

The latest price target for Citius Pharmaceuticals (NASDAQ: CTXR) was reported by Maxim Group on November 30, 2021. The analyst firm set a price target for 4.00 expecting CTXR to rise to within 12 months (a possible 164.90% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Citius Pharmaceuticals (CTXR)?

A

The stock price for Citius Pharmaceuticals (NASDAQ: CTXR) is $1.51 last updated Fri Dec 03 2021 21:00:04 GMT+0000 (Coordinated Universal Time).

Q

Does Citius Pharmaceuticals (CTXR) pay a dividend?

A

There are no upcoming dividends for Citius Pharmaceuticals.

Q

When is Citius Pharmaceuticals (NASDAQ:CTXR) reporting earnings?

A

Citius Pharmaceuticals’s $Q1 earnings are confirmed for after-market on February 10, 2022.

Q

Is Citius Pharmaceuticals (CTXR) going to split?

A

There is no upcoming split for Citius Pharmaceuticals.

Q

What sector and industry does Citius Pharmaceuticals (CTXR) operate in?

A

Citius Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.